Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,317,701
+$60,111 QoQ
Shares Held
8,408
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#546
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simmons Bank holds $67,934,657 across 11 Drug Manufacturers - General names. NVS ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
51,844 | $13,046,023 | |
| 2 | LLY |
ELI LILLY & Co
|
10,864 | $13,030,606 | |
| 3 | AMGN |
Amgen Inc
|
26,161 | $9,473,419 | |
| 4 | MRK |
Merck & Co., Inc.
|
70,419 | $9,048,841 | |
| 5 | JNJ |
Johnson & Johnson
|
35,136 | $8,923,488 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
37,464 | $4,733,201 | |
| 7 | PFE |
Pfizer Inc
|
125,117 | $3,012,817 | |
| 8 | GSK |
GSK plc
|
57,449 | $3,011,475 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,317,701 | 8,408 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,257,590 | 8,233 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,146,113 | 8,313 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,117,354 | 8,713 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,056,296 | 8,729 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,022,716 | 9,174 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $896,419 | 9,212 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,068,190 | 9,287 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,013,392 | 9,519 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $940,601 | 9,724 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $980,619 | 9,712 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $989,264 | 9,712 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $991,742 | 9,828 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $915,216 | 9,948 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $937,681 | 10,336 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $786,398 | 10,346 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $923,573 | 10,926 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,027,639 | 11,711 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,042,904 | 11,923 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $982,504 | 12,014 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,126,540 | 12,347 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,116,026 | 13,056 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,276,220 | 13,515 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,617,194 | 18,597 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,706,273 | 19,536 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,408,410 | 17,082 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||